MasterCard: Intends to establish a wholly-owned subsidiary in Macau

Notice of Wanlili Corporation: The company plans to establish Macao Mingyang Health Industry Co., Ltd. in Macao with its own funds, mainly engaged in the outsourcing processing, research and development, quality inspection, operation, and sales of protein peptides extracted from silk cocoons of the unique variety of Wanlili "Wanlili Jincan No.1" using Pickering self-assembly technology. The total investment amount for this external investment plan is 25 million yuan within three years, fulfilling the ODI filing procedures. The first phase of investment is expected to be 10 million yuan, with additional investments to be gradually added in the following three years according to the actual operational needs of the Macao company.